Movano health announces completion of clinical study with cuffless rf blood pressure device

New hardware boasts significant improvements to reduce noise and generate higher fidelity signals pleasanton, calif. , nov. 7, 2024 /prnewswire/ -- movano health inc. (nasdaq: move) announced today that it has tested its newly developed blood pressure wrist wearable as part of its november 5 th and 6th hypoxia clinical trial that took place at the university of california, san francisco.
MOVE Ratings Summary
MOVE Quant Ranking